
浏览全部资源
扫码关注微信
400016 重庆,重庆医科大学附属第一医院呼吸与危重症医学科
[江涛,E-mail:j.tcq@163.comJIANG Tao, E-mail:j.tcq@163.com
收稿:2018-11-12,
修回:2018-12-19,
纸质出版:2019-05-15
移动端阅览
罗勤利, 邓小垭, 董飞, 等. RNA结合蛋白TTP对肺腺癌细胞增殖影响的实验研究[J]. 第三军医大学学报, 2019,41(9):851-858.
Qinli LUO, Xiaoya DENG, Fei DONG, et al. RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells
罗勤利, 邓小垭, 董飞, 等. RNA结合蛋白TTP对肺腺癌细胞增殖影响的实验研究[J]. 第三军医大学学报, 2019,41(9):851-858. DOI: 10.16016/j.1000-5404.201811085.
Qinli LUO, Xiaoya DENG, Fei DONG, et al. RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells
目的
2
探讨TTP(tritetraprolin)过表达对肺腺癌细胞增殖影响及其可能的作用机制。
方法
2
构建带有四环素可调控(tetracycline-on,Tet-on)的TTP基因表达系统,利用慢病毒感染的方法转染肺腺癌H1975及1299细胞,并在强力霉素(doxycycline,Dox)的诱导下稳定表达TTP。用实时荧光定量PCR和Western blot鉴定TTP受Dox调控表达的效果。分别采用CCK-8法、Transwell、平板克隆形成实验、流式细胞术检测TTP过表达后对细胞增殖、迁移、集落形成能力、凋亡和细胞周期的影响。Western blot法检测TTP过表达对凋亡基因在蛋白水平表达的影响。
结果
2
成功构建受Dox诱导调控的TTP过表达肺腺癌细胞模型。与TTP低表达组比较,Dox诱导TTP过表达组明显抑制H1975、H1299细胞增殖、迁移能力(H1975 :
P
<
0.01
H1299:
P
<
0.001)及集落形成能力(
P
值均
<
0.0001),且使H1975细胞周期被阻滞在S期(
P
<
0.01),但TTP过表达不影响肺腺癌细胞凋亡。
结论
2
TTP过表达显著抑制肺腺癌细胞增殖、迁移、集落形成能力,使细胞周期被阻滞在S期,但TTP过表达不通过细胞凋亡途径影响肺腺癌细胞增殖和生长。
Objective
2
To investigate the effect of tristetraprolin (TTP) on the proliferation of lung cancer cells and to explore the possible mechanism.
Methods
2
The human lung adenocarcinoma cells with tetracycline-inducible (Tet-on) expression regulatory system were established in H1975 and 1299 cells with the aid of lentivirus infection. Western blotting and q-PCR were used to confirm the overexpression of TTP in the cells after the doxycycline (Dox) treatment. Effect of TTP on the proliferation
migration and colony-forming capacity were detected by CCK-8 assay
Transwell test and colony forming unit test respectively. The cell apoptosis and cell cycle were measured by flow cytometry. The expression of cellular apoptosis-related proteins were determined by Western blotting.
Results
2
Lung adenocarcinoma cells with Dox-induced TTP overexpression were successfully established. Compared with the cells with low TTP expression
those with Dox-induced TTP overexpression siginicantly inhibited proliferation
migration(H1975:
P
<
0.01
H1299:
P
<
0.001)and colony-formation (all
P
<
0.0001) in lung adenocarcinoma cells H1975 and H1299. What's more
H1975 cells were arrested at S stage (
P
<
0.01). However
TTP overexpression exerted no effect on cell apoptosis.
Conclusion
2
TTP overexpression obviously inhibits proliferation
migration and colony-forming capacity
and arrests cell cycle at S stage in lung adenocarcinoma cells. But the mechanism is not due to the regulation of cell apoptosis.
OGILVIE R L, ABELSON M, HAU H H, et al . Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay[J ] . J Immunol, 2005, 174(2): 953-961. DOI:10.4049/jimmunol.174.2.953.
WEI Z R, LIANG C, FENG D, et al . Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer[J ] . Oncotarget, 2016, 7(14): 17737-17750. DOI:10.18632/oncotarget.7397.
GODDIO M V, GATTELLI A, SLOMIANSKY V, et al . Mammary differentiation induces expression of tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein[J ] . Breast Cancer Res Treat, 2012, 135(3): 749-758. DOI:10.1007/s10549-012-2216-0.
HALEES A S, EL-BADRAWI R, KHABAR K S. ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse[J]. Nucleic Acids Res, 2008, 36(Database issue): D137-D140. DOI:10.1093/nar/gkm959.
BLACKSHEAR P J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover[J]. Biochem Soc Trans, 2002, 30(Pt 6): 945-952. DOI:10.1042/.
BAOU M, JEWELL A, MUTHURANIA A, et al . Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells[J ] . Leukemia, 2009, 23(5): 986-989. DOI:10.1038/leu.2008.340.
GUO J, QU H, CHEN Y, et al . The role of RNA-binding protein tristetraprolin in cancer and immunity[J ] . Med Oncol, 2017, 34(12): 196. DOI:10.1007/s12032-017-1055-6.
JELTSCH K M, HEISSMEYER V. Regulation of T cell signaling and autoimmunity by RNA-binding proteins[J]. Curr Opin Immunol, 2016, 39: 127-135. DOI:10.1016/j.coi.2016.01.011.
FALLAHI M, AMELIO A L, CLEVELAND J L, et al . CREB targets define the gene expressio n signature of malignancies having reduced levels of the tumor suppressor tristetraprolin[J ] . PLoS ONE, 2014, 9(12): e115517. DOI:10.1371/journal.pone.0115517.
FU M, BLACKSHEAR P J. RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins[J]. Nat Rev Immunol, 2017, 17(2): 130-143. DOI:10.1038/nri.2016.129.
BROOKS S A, BLACKSHEAR P J. Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action[J]. Biochim Biophys Acta, 2013, 1829(6/7): 666-679. DOI:10.1016/j.bbagrm.2013.02.003.
GRUBER A R, FALLMANN J, KRATOCHVILL F, et al . AREsite: a database for the comprehensive investigation of AU-rich elements[J ] . Nucleic Acids Res, 2011, 39(Database issue): D66-D69. DOI:10.1093/nar/gkq990.
KHABAR K S A. Hallmarks of cancer and AU-rich elements[J]. Wiley Interdiscip Rev: RNA, 2016, 8(1): e1368. DOI:10.1002/wrna.1368.
BISOGNO L S, KEENE J D. RNA regulons in cancer and inflammation[J]. Curr Opin Genet Dev, 2018, 48: 97-103. DOI:10.1016/j.gde.2017.11.004.
MUKHERJEE N, JACOBS N C, HAFNER M, et al . Global target mRNA specification and regulation by the RNA-binding protein ZFP36[J ] . Genome Biol, 2014, 15(1): R12. DOI:10.1186/gb-2014-15-1-r12.
MUSGROVE E A, CALDON C E, BARRACLOUGH J, et al . Cyclin D as a therapeutic target in cancer[J ] . Nat Rev Cancer, 2011, 11(8): 558-572. DOI:10.1038/nrc3090.
LEE H H, LEE S R, LEEM S H. Tristetraprolin regulates prostate cancer cell growth through suppression of E2F1[J]. J Microbiol Biotechnol, 2014, 24(2): 287-294. DOI:10.4014/jmb.1309.09070.
LEE S R, ROH Y G, KIM S K, et al . Activation of EZH2 and SUZ12 regulated by E2F1 predicts the disease progression and aggressive characteristics of bladder cancer[J ] . Clin Cancer Res, 2015, 21(23): 5391-5403. DOI:10.1158/1078-0432.CCR-14-2680.
ZHANG Y, WANG Z, MAGNUSON N S. Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299cells[J]. Mol Cancer Res, 2007, 5(9): 909-922. DOI:10.1158/1541-7786.MCR-06-0388.
ROUNBEHLER R J, FALLAHI M, YANG C, et al . Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state[J ] . Cell, 2012, 150(3): 563-574. DOI:10.1016/j.cell.2012.06.033.
SANDUJA S, KAZA V, DIXON D A. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase[J]. Aging (Albany NY), 2009, 1(9): 803-817. DOI:10.18632/aging.100086.
GUO J, QU H, SHAN T, et al . Tristetraprolin overexpression in gastric cancer cells suppresses PD-L1 expression and inhibits tumor progression by enhancing antitumor immunity[J ] . Mol Cells, 2018, 41(7): 653-664. DOI:10.14348/molcells.2018.0040.
TRAN D D H, KOCH A, ALLISTER A, et al . Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP)[J ] . Cell Signall, 2016, 28(12): 1872-1880. DOI:10.1016/j.cellsig.2016.09.002..
DONG F, LI C, WANG P, et al . The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells[J ] . Exp Cell Res, 2018, 367(1): 89-96. DOI:10.1016/j.yexcr.2018.03.028.
COELHO M A, DE CARNÉ TRÉCESSON S, RANA S, et al . Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA[J ] . Immunity, 2017, 47(6): 1083-1099.e6. DOI:10.1016/j.immuni.2017.11.016.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621